Republican candidate Scott Esk lost the Oklahoma House District 87 runoff after past comments calling it “totally just” to ...

The actress just launched her first-ever skincare product in collaboration with Australian-based evidence skincare brand, ESK, and it's designed with delicate skin in mind. Rebecca Minkoff Gets ...

NEW YORK, Sept. 24, 2025 /PRNewswire/ -- ESK, the Australian evidence-based cosmeceutical skincare brand, today announced its first-ever product innovation co-developed with actress, activist and ...

Add Yahoo as a preferred source to see more of our stories on Google. A Republican candidate for the Oklahoma state House has come under fire for comments, unearthed from a 2013 Facebook thread, in ...

ESK, the Australian cosmeceutical brand cofounded by Dr. Ginni Mansberg and Daniel Rubinstein, has found a new celebrity collaborator. Enter Selma Blair, who codeveloped the brand’s Ultimate A Gold, a ...

These 28-week data on twice-daily ESK-001 highlight the drug’s safety and efficacy among patients with psoriasis. ESK-001 is generally effective and well-tolerated among individuals with ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Selma Blair may be best known for starring in classics like Cruel Intentions and Legally Blonde, but she’s recently added another impressive gig to her résumé. The actress just teamed up with the ...

Alumis announced positive Phase 2 OLE results for ESK-001, a TYK2 inhibitor for moderate-to-severe plaque psoriasis, showing sustained clinical improvements. Alumis Inc. has announced positive 52-week ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. ESK-001, a tyrosine kinase 2 inhibitor, may be a ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Alumis Inc., a precision immunology company that is reimagining the discovery, development and treatment of autoimmune disorders, today announced that the ...

Alumis Inc. has announced the successful completion of patient enrollment in its pivotal Phase 3 ONWARD clinical program for ESK-001, a treatment for moderate-to-severe plaque psoriasis, involving ...